Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The glycine receptor

S Rajendra1, J W Lynch, P R Schofield

  • 1School of Physiology and Pharmacology, University of New South Wales, Sydney, Australia.

Pharmacology & Therapeutics
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal pre-pregnancy body mass index and risk of preterm birth: a collaboration using large routine health datasets.

BMC medicine·2024
Same author

Use of Ceftriaxone and Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Spectrum vs Cost.

Open forum infectious diseases·2023
Same author

Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease.

medRxiv : the preprint server for health sciences·2023
Same author

Elective labor induction vs expectant management of pregnant women at term and children's educational outcomes at 8 years of age.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
Same author

Circulating human papillomavirus DNA detection in Barrett's dysplasia and esophageal adenocarcinoma.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2019
Same author

Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2019
Same journal

Protein acetylation modification in tissue fibrosis: Opportunities and challenges.

Pharmacology & therapeutics·2026
Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026
See all related articles

The inhibitory glycine receptor (GlyR), a chloride channel in the central nervous system, plays a key role in neurotransmission. Research integrates its properties with genetic insights into disorders of glycinergic neurotransmission.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The inhibitory glycine receptor (GlyR) is a crucial ligand-gated ion channel in the central nervous system.
  • It forms a pentameric complex, creating a chloride-selective transmembrane channel.
  • GlyR is primarily expressed in the spinal cord and brain stem.

Purpose of the Study:

  • To review the pharmacological and physiological properties of the GlyR.
  • To integrate recent findings from GlyR subunit cloning and recombinant expression.
  • To discuss GlyR structure-function insights from genetic disorders of glycinergic neurotransmission.

Main Methods:

  • Literature review of GlyR properties.
  • Analysis of data from cloning and recombinant expression studies.

Related Experiment Videos

  • Examination of genetic characterization of heritable disorders affecting glycinergic neurotransmission.

    • Main Results:

    • Compilation of established pharmacological and physiological characteristics of GlyR.
    • Integration of new knowledge on GlyR subunit function and structure.
    • Correlation of genetic mutations with altered glycinergic neurotransmission.

    Conclusions:

    • The GlyR is a vital component of inhibitory neurotransmission.
    • Understanding GlyR structure and function is enhanced by molecular and genetic approaches.
    • Genetic disorders provide critical insights into GlyR's role in neurological function.